Gene expression in uninvolved oral mucosa of OSCC patients facilitates identification of markers predictive of OSCC outcomes

dc.contributor.advisorChen, Chuen_US
dc.contributor.authorLohavanichbutr, Pawadeeen_US
dc.date.accessioned2012-09-13T17:21:59Z
dc.date.available2015-12-14T17:55:46Z
dc.date.issued2012-09-13
dc.date.submitted2012en_US
dc.descriptionThesis (Master's)--University of Washington, 2012en_US
dc.description.abstractOral and oropharyngeal squamous cell carcinomas (OSCC) are among the most common cancers worldwide with approximately 60% 5-yr survival rate. To identify potential markers for disease progression, we used Affymetrix U133 plus 2.0 arrays to examine the gene expression profiles of 167 primary tumor samples from OSCC patients, 58 uninvolved oral mucosa from OSCC patients and 45 normal oral mucosa from patients without oral cancer, all of whom were enrolled at one of the three University of Washington-affiliated medical centers from 2003 to 2008. We found 2,596 probe sets differentially expressed between 167 tumor samples and 45 normal samples. Among 2,596 probe sets, 71 were significantly and consistently up- or down-regulated in the comparison between normal samples and uninvolved oral samples and between uninvolved oral samples and tumor samples. Cox regression analyses showed that 20 of the 71 probe sets were significantly associated with progression-free survival. The risk score for each patient was calculated from coefficients of a Cox model incorporating these 20 probe sets. The hazard ratio (HR) associated with each unit change in the risk score adjusting for age, gender, tumor stage, and high-risk HPV status was 2.7 (95% CI: 2.0-3.8, p = 8.8E-10). The risk scores in an independent dataset of 74 OSCC patients from the MD Anderson Cancer Center was also significantly associated with progression-free survival independent of age, gender, and tumor stage (HR 1.6, 95% CI: 1.1 - 2.2, p = 0.008). Gene Set Enrichment Analysis showed that the most prominent biological pathway represented by the 71 probe sets was integrin cell surface interactions pathway. In conclusion, we identified 71 probe sets in which dysregulation occurred in both uninvolved oral samples and cancer samples. Dysregulation of 20 of the 71 probe sets was associated with progression-free survival and was validated in an independent dataset.en_US
dc.embargo.termsDelay release for 2 years -- then make Open Accessen_US
dc.format.mimetypeapplication/pdfen_US
dc.identifier.otherLohavanichbutr_washington_0250O_10235.pdfen_US
dc.identifier.urihttp://hdl.handle.net/1773/20514
dc.language.isoen_USen_US
dc.rightsCopyright is held by the individual authors.en_US
dc.subjectgene expression; oral cancer; survivalen_US
dc.subject.otherEpidemiologyen_US
dc.subject.otherEpidemiologyen_US
dc.titleGene expression in uninvolved oral mucosa of OSCC patients facilitates identification of markers predictive of OSCC outcomesen_US
dc.typeThesisen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Lohavanichbutr_washington_0250O_10235.pdf
Size:
163.54 KB
Format:
Adobe Portable Document Format

Collections